Form 4 · Filed Mar 5, 2026, 12:00 PM UTC
OLMA/Olema Pharmaceuticals, Inc.
Mitchell Shawnte — CHIEF LEGAL OFFICER
Pro feature
Read the AI thesis behind every Form 4 — only on Pro and Premium
Free accounts see filings 24 hours late and the thesis is hidden until then. Upgrade to read every Form 4 the moment it hits EDGAR, with a Sonnet-4.6 (or Opus-4.7 on flagged buys) thesis attached.
Free
FreeBrowse the last 30 days of insider filings. Weekly digest by email.
- · Last 30 days of filings (list view)
- · Conviction score badge on each filing
- · Insider profiles & edge scores
Pro
$15/moAI thesis on every filing + watchlist email alerts.
- · Full AI thesis on every Form 4 (Sonnet 4.6)
- · Full filing history (no 30-day cap)
- · Unlimited ticker watchlists
Premium
$49/moOpus 4.7 deep theses + SMS alerts + cluster-buy detection.
- · Everything in Pro
- · Opus-grade thesis on flagged buys
- · SMS alerts for highest-conviction filings
Transactions
7 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | S | sell | 24,767 | $24 | $600,600 | 233 |
| Mar 4, 2026 | M | other | 25,000 | $4 | $109,250 | 25,000 |
| Mar 4, 2026 | S | sell | 233 | $25 | $5,753 | 0 |
| Mar 4, 2026 | M | other | 25,000 | $0 | — | 410,000 |
| Mar 3, 2026 | S | sell | 15,000 | $23 | $345,150 | 0 |
| Mar 3, 2026 | M | other | 15,000 | $0 | — | 435,000 |
| Mar 3, 2026 | M | other | 15,000 | $4 | $65,550 | 15,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001749432-26-000004